Sterling Hospitals, Ahmedabad, successfully performed a complex Robotic Whipple surgery, offering new hope in pancreatic cancer treatment with minimal invasiveness and faster recovery.
Moderna and Merck’s personalized skin cancer vaccine shows a 49% reduction in recurrence risk after five years, offering new hope for high-risk melanoma patients.
Novo Nordisk expands its diabetes cell therapy partnership with Aspect Biosystems, aiming to develop implantable insulin-producing cells and advance next-generation treatments for type 1 diabetes patients.
AstraZeneca has acquired AbelZeta Pharma’s remaining China rights to the CAR-T therapy C-CAR031, gaining full global control while positioning the program for broader development in liver cancer and solid tumors.
Dentalkart partners with NSK Japan to offer authentic dental equipment in India with transparent pricing and faster after-sales support.
Pfizer exits ViiV Healthcare in $1.9B deal, Shionogi doubles stake to 21.7%, while GSK retains majority, advancing long-acting HIV treatments and prevention.
GSK has agreed to acquire RAPT Therapeutics for $2.2 billion, adding ozureprubart, a long-acting anti-IgE antibody, to its pipeline and strengthening its push into food allergy treatment.
Syngene International has extended its strategic research collaboration with Bristol Myers Squibb through 2035, expanding integrated services across discovery, development, manufacturing, and clinical programs.
Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful day-long symposium brought together eminent voices, leaders, and experts from across India’s life sciences and clinical...
Granules India is actively exploring acquisitions in the injectables segment, with deal sizes capped at $50 million, as it targets quality-led growth amid global shortages and rising demand for complex formulations.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")